Cetrizine di hcl

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us fo...

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftiofur sodium sterile & ceftiofur hcl. It belongs to cephalosporins apis products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Cont...

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg. It belobgs to antibacterial cephalosporins finish formulations products c...

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes certrorelix acetate injection (0.25 / vial). It belongs to gynaecology finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrorelix acetate. It belongs to infertility apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetuximab. It belongs to monoclonal antibodies apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate. It belongs to antialzheimer apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate 400 mg soft caps & 250 mg/ml injection. It belongs to central nervous system finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cisplatin injection 10 mg/ 50 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citalopram hydrobromide. It belongs to antideperessant apis category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.